Pathophysiologie — Hämodynamik und Reflexe

  • K. J. Osterziel
Part of the Aktuelle Therapieprinzipien in Kardiologie und Angiologie book series (THERAPIEPRINZ.)


Bei einem Abfall des Herzzeitvolumens spielen 3 gegenregülatorische Mechanismen eine wichtige Rolle


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abboud FM, Thames MD (1983) Interaction of cardiovascular reflexes in circulatory control. In: Shepherd JT et al. (eds) The cardiovascular system III. Waverly, Baltimore (Handbook of physiology, pp 675–753)Google Scholar
  2. 2.
    Anand IS, Ferrari R, Kalra GS, Wahi PL, Poole-Wüson PA, Harris PC (1989) Edema of cardiac origin. Studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive heart failure. Circulation 80:299–305Google Scholar
  3. 3.
    Atkinson AB, Robertson JIS (1979) Captopril in the treatment of clinical hypertension and cardiac failure. Lancet 836–839Google Scholar
  4. 4.
    Bishop VS, Malliani A, Thoren P (1983) Cardiac mechanoreceptors. In: Shepherd JT et al. (eds) The cardiovascular system III. Waverly, Baltimore (Handbook of physiology, pp 497–555)Google Scholar
  5. 5.
    Bonjour JP, Malvin RL (1970) Stimulation of ADH release by the reninangiotensin system. Am J Physiol 218:1555–1559PubMedGoogle Scholar
  6. 6.
    Braunwald E (1988) Pathophysiology of heart failure. In: Braunwald E (ed) Heart disease. Saunders, Philadelphia PA, pp 426–448Google Scholar
  7. 7.
    Braunwald E, Sonnenblick EH, Ross J (1988) Mechanisms of cardiac contraction and relaxation. In: Braunwald E (ed) Heart disease. Saunders, Philadelphia PA, pp 383–425Google Scholar
  8. 8.
    Brunner DB, Burnier HR (1983) Plasma vasopressin in rats: effect of sodium, angiotensin and catecholamines. Am J Physiol 244:H259-H265PubMedGoogle Scholar
  9. 9.
    Cannon PJ (1983) A placebo-controlled trial of Captopril in refractory chronic congestive heart failure. J Am Coll Cardiol 2:755–763CrossRefGoogle Scholar
  10. 10.
    CONSENSUS Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 316:1429–1435CrossRefGoogle Scholar
  11. 11.
    Cowley AW, Switzer SJ, Skeleton MM (1981) Vasopressin, fluid and electrolyte response to chronic angiotensin II infusion. Am J Physiol 240:R130-R138PubMedGoogle Scholar
  12. 12.
    Cowley AW, Qillen ED, Skelton MM (1983) Role of vasopressin in cardiovascular regulation. Fed Proc 42:No 15Google Scholar
  13. 13.
    Craeger MA, Massie BM, Faxon DP et al. (1985) Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure. J Am Coll Cardiol 6:163–170CrossRefGoogle Scholar
  14. 14.
    Creager MA, Faxon DP, Cutler SS et al. (1986) Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: Comparison with the reninangiotensin system and the sympathetic nervous system. J Am Coll Cardiol 7:758–766PubMedCrossRefGoogle Scholar
  15. 15.
    Distler A (1988) Hemmstoffe des Angiotensin-Conversionsenzyms (ACE-Hemmer). Dtsch Ärztebl 44:3071–3073Google Scholar
  16. 16.
    Dunn FG, Oigman W, Ventura HO, Messerli FH, Kobrin I, Fröhlich ED (1984) Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertension. Am J Cardiol 53:105–108PubMedCrossRefGoogle Scholar
  17. 17.
    Dzau VJ (1988) Circulating vs localrenin-angiotensin system in cardiovascular homeostasis. Circulation [Suppl I] 77:1–4–1–13CrossRefGoogle Scholar
  18. 18.
    Eckberg DL, Drabinsky M, Braunwald E (1971) Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med 285:877–883PubMedCrossRefGoogle Scholar
  19. 19.
    Edwards CRW, Padfield PL (1985) Angiotensin-Converting enzyme inhibitors: Past, present, and bright future. Lancet 30–34Google Scholar
  20. 20.
    Egan B, Fitzpatrick A, Julius S (1987) The heart and the regulation of renin. Circulation [Suppl I] 75:1–130-1–133Google Scholar
  21. 21.
    Ellenbogen KA, Mohanty PK, Szentpetery S, Thames MD (1989) Arterial baroreflex abnormalities in heart failure. Reversal after orthotopic cardiac transplantation. Circulation 79:51–58PubMedCrossRefGoogle Scholar
  22. 22.
    Foult JM, Tavolaro O, Antony I, Nitenberg A (1988) Direct myocardial and coronary effects of enalaprilat in patients with dilated cardiomyopathy: Assessment by a bilateral intracoronary infusion technique. Circulation 77:337–344PubMedCrossRefGoogle Scholar
  23. 23.
    Francis GS (1988) Neuroendocrine manifestations of congestive heart failure. Am J Cardiol 62:9A-13APubMedCrossRefGoogle Scholar
  24. 24.
    Goldsmith SR, Francis GS, Cowley AW, Levine TB, Cohn JN (1983) Increased plasma arginine vasopressin levels in patients with congestive heart failure. J Am Coll Cardiol 6:49–52Google Scholar
  25. 25.
    Goldstein RE, Beiser GD, Stampfer M, Epstein SE (1975) Impairment of autonomically mediated heart rate control in patients with cardiac dysfunction. Circ Res 36:571–578PubMedGoogle Scholar
  26. 26.
    Grandi AM, Venco A, Barzizza F, Casadei B, Marchesi E, Finardi G (1989) Effect of enalapril on left ventricular mass and performance in essential hypertension. Am J Cardiol 63:1093–1097PubMedCrossRefGoogle Scholar
  27. 27.
    Greenberg TT, Richmond WT, Stocking RA, Gupta PD, Meehan JP, Henry JP (1973) Impaired atrial receptor responses in dogs with heart failure due to tricuspid insufficiency and pulmonary artery stenosis. Circ Res 32:424–433PubMedGoogle Scholar
  28. 28.
    Hall JE, Guyton AC, Jackson TE, Coleman TG, Lohmeier TE, Trippodo NC (1977) Control of glomerular filtration rate by renin-angiotensin system. Am J Physiol 233:F366-F372PubMedGoogle Scholar
  29. 29.
    Hirsch AT, Dzau VJ, Creager MA (1987) Baroreceptor function in congestive heart failure: Effect on neurohumoral activation and regional vascular resistance. Circulation [Suppl IV] 75: IV36-IV48Google Scholar
  30. 30.
    Hoffman H, Covell J (1984) Relationship between ejection phase indices of performance and myocardial function during the development of pressure overload hypertrophy. Am Heart J 107:738–744PubMedCrossRefGoogle Scholar
  31. 31.
    Ischikawa I, Pfeffer JM, Pfeffer MA, Hostetter TH, Brenner BM (1984) Role of angiotensin II in the altered renal function of congestive heart failure. Circ Res 55:669–675Google Scholar
  32. 32.
    Jin M, Wilhelm MJ, Lang RE, Lindpainter K, Ganten D (1988) Endogenous tissue reninangiotensin systems. From molecular biology to therapy. Am J Med [Suppl 3 A] 84:28–36Google Scholar
  33. 33.
    Katz AM (1990) Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. N Engl J Med 322:100–110PubMedCrossRefGoogle Scholar
  34. 34.
    Kramer BL, Massie BM, Topic N (1983) Controlled trial of Captopril in chronic heart failure: A rest and exercise hemodynamic study, Circulation 67:807–816PubMedCrossRefGoogle Scholar
  35. 35.
    Kromer EP, Riegger GAJ (1988) Effects of long-term angiotensin converting enzyme inhibition on myocardial hypertrophy in experimental aortic stenosis in the rat. Am J Cardiol 62:161–163PubMedCrossRefGoogle Scholar
  36. 36.
    Lindpainter K, Jin M, Wilhelm MJ, Suzuki F (1988) Intracardiac generation of angiotensin and its physiologic role. Circulation [Suppl I] 77:1–18-1–23CrossRefGoogle Scholar
  37. 37.
    Mancia G, Mark AL (1983) Arterial baroreflexes in humans. In: Shepherd JT et al. (eds) The cardiovascular system III. Waverly, Baltimore (Handbook of physiology, pp 755–813)Google Scholar
  38. 38.
    Manthey J, Dietz R, Hackenthal E et al. (1984) Linksventrikuläre Funktion und Aktivität vasopressorischer Systeme bei Patienten mit chronischer Herzinsuffizienz. Z Kardiol 73:279–288PubMedGoogle Scholar
  39. 39.
    Michell RH, Kirk C, Billah MM (1979) Hormonal Stimulation of phosphoinositol breakdown with particular reference to the heaptic effects of vasopressin. Biochem Soc Trans 7:861–865PubMedGoogle Scholar
  40. 40.
    Morel F (1981) Sites of hormone action in the mammalian nephron. Am J Physiol 240:F159-F164PubMedGoogle Scholar
  41. 41.
    Morris BJ, Davis JO, Zatzman ML, Williams GM (1977) The renin-angiotensin-aldosterone system in rabbits with congestive heart failure produced by aortic constriction. Circ Res 40:275–282PubMedGoogle Scholar
  42. 42.
    Nakashima Y, Fouad FM, Tarazi RC (1984) Regression of left ventricular hypertrophy from hypertension by enalalpril. Am J Cardiol 53:1044–1049PubMedCrossRefGoogle Scholar
  43. 43.
    Nicod P, Waeber B, Bussin J-P et al. (1985) Acute hemodynamic effect of a vascular antagonist of vasopressin in patients with congestive heart failure. Am J Cardiol 55:1043–1047PubMedCrossRefGoogle Scholar
  44. 44.
    Osterziel KJ, Dietz R, Schmid W, Kübler W (1988) Reflektorische Regulation der Herzfrequenz bei herzinsuffizienten Patienten. Z Kardiol 77:576–581PubMedGoogle Scholar
  45. 45.
    Osterziel KJ, Dietz R, Schnmid W, Mikulaschek K, Kübler W (1989) ACE Inhibitors improve vagal reactivity in patients with heart failure. Eur Heart J [Suppl] 10:228Google Scholar
  46. 46.
    Packer M (1985) Is the renin-angiotensin system really unnecessary in patients with severe chronic heart failure: The price we pay for interfering with evolution. J Am Coll Cardiol 6:171–173CrossRefGoogle Scholar
  47. 47.
    Packer M (1987) Why do the kidneys release renin in patients with congestive heart failure? A nephrocentric view of converting-enzyme inhibition. Am J Cardiol 60:179–183PubMedCrossRefGoogle Scholar
  48. 48.
    Pfeffer MA, Pfeffer JM, Steinberg C, Finn P (1985) Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with Captopril. Circulation 72:406–412PubMedCrossRefGoogle Scholar
  49. 49.
    Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E (1988) Effect of Captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 319:80–86PubMedCrossRefGoogle Scholar
  50. 50.
    Re R, Rovigatti U (1988) New approaches to the study of the cellular biology of the cardiovascular system. Circulation [Suppl I] 77:1–14-1–17CrossRefGoogle Scholar
  51. 51.
    Riegger AJG (1985) Neurohumoral vasoconstrictor systems in heart failure. Eur Heart J 6:479–489PubMedGoogle Scholar
  52. 52.
    Riegger AJG, Liebau G (1982) The renin-angiotensin-aldosterone system, antidiuretic hormone and sympathetic nerve activity in an experimental model of congestive heart failure in the dog. Clin Sci 62:465–469.PubMedGoogle Scholar
  53. 53.
    Riegger AJG, Liebau G, Kochsiek K (1982) Antidiuretic hormone in congestive heart failure. Am J Med 72:49–52PubMedCrossRefGoogle Scholar
  54. 54.
    Riegger GAJ, Liebau G, Holzschuh M, Witkowsky D, Steilner H, Kochsiek K (1984) Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting-enzyme blockade. Am J Cardiol 53:614–618PubMedCrossRefGoogle Scholar
  55. 55.
    Riegger AJG, Liebau G, Bauer E, Kochsiek K (1985) Vasopressin and renin in high output heart failure of rats: Hemodynamic effects of elevated plasma hormone levels. J Cardiovasc Pharmacol 7:1–5PubMedCrossRefGoogle Scholar
  56. 56.
    Riegger AJG, Albert M, Kochsiek K (1988) Cardiovascular effects of AVP and ANG in experimental pulmonic stenosis in rats. Am J Physiol 254:H438-H442PubMedGoogle Scholar
  57. 57.
    Robertson GL (1986) Osmotic and hemodynamic control of vasopressin: Functional and anatomical relationships. Adv Physiol Sci 11:537–546Google Scholar
  58. 58.
    Russel JT, Brownstein MJ, Gainer H (1981) Time course of appearance and relese of cysteine-labelled neurophysins and peptides in the neurohypophysis. Brain Res 205:299–311CrossRefGoogle Scholar
  59. 59.
    Sachs H, Portanova R, Haller EW, Share L (1987) Cellular process concerned with vasopressin biosynthesis, storage and release. In: Stutinsky F (ed) Neurosecretion. Springer, Berlin Heidelberg New York TokyoGoogle Scholar
  60. 60.
    Schmieder RE, Messerli FH, Garavaglia GE, Nunez B, MacPhee AA, Re RE (1988) Does the renin-angiontensin-aldosterone system modify cardiac structure and function in essential hypertension? Am J Med [Suppl 3 A] 84:136–139Google Scholar
  61. 61.
    Schrier RW, Berl T, Anderson RJ (1979) Osmotic and nonosmotic control of vasopressin release. Am J Physiol 236:F321-F332PubMedGoogle Scholar
  62. 62.
    Sharpe N, Murphy J, Smith H, Hannan S (1988) Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet 8580:255–259CrossRefGoogle Scholar
  63. 63.
    Spann JF, Buccino RA, Sonnenblick EH, Braunwald E (1967) Contractile state of cardiac muscle obtained from cats with experimentally produced ventricular hypertrophy. Circ Res 21:341–348PubMedGoogle Scholar
  64. 64.
    Stone CK, Chang-seng L, Naoaki I, Sakamoto S, Sladek C, Hood WB (1988) Short-term hemodynamic effects of vasopressin VI-receptor inhibition in chronic right-sided congestive heart failure. Circulation 78:1251–1259PubMedCrossRefGoogle Scholar
  65. 65.
    Szatalowicz VL, Arnold PE, Chaimovitz C, Bichet D, Berl T, Schrier RW (1981) Radioimmunoassay of plasma arginine vasopressin in hyponatremic patients with congestive heart failure. N Engl J Med 305:263–269PubMedCrossRefGoogle Scholar
  66. 66.
    Todd PAR, Heel RC (1986) Enalapril: A review of its pharmacodynamic and pharmacokinatic properties, and therapeutic use in hypertension and congestive heart failure. Drugs 31:198–248PubMedCrossRefGoogle Scholar
  67. 67.
    Verdecchia P, Schillaci G, Guerrieri M, Gatteschi C, Benemio G, Boldrini F, Porcellati C (1990) Orcadian blood pressure changes and left ventricular hypertrophy in essential hypertension. Circulation 81:528–536PubMedCrossRefGoogle Scholar
  68. 68.
    Watkins L, Burton JA, Haber E, Cant JR, Smith FW, Barger AC (1976) The renin-angiotensin-aldosterone system in congestive failure in conscious dogs. J Clin Invest 57:1606–1617PubMedCrossRefGoogle Scholar
  69. 69.
    Weber KT, Janicki JS, Shroff SG, Pick R, Chen RM, Bashey RI (1988) Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Circ Res 62:757–765PubMedGoogle Scholar
  70. 70.
    Wilson JR, Douglas P, Hickey WF, Lanoce V, Ferraro N, Muhammad A, Reichek N (1987) Experimental congestive heart failure produced by repid ventricular pacing in the dog: Cardiac effects. Circulation 75:857–867PubMedCrossRefGoogle Scholar
  71. 71.
    Zucker IH, Earle A, Gilmore J (1977) The mechanism of adaptation of left atrial stretch receptors in dogs with chronic heart failure. J Clin Invest 60:323–331PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • K. J. Osterziel

There are no affiliations available

Personalised recommendations